Zenith Drugs (NSE:ZENITHDRUG) Other Operating Expense: ₹426 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
36 GF Score
Price ₹42.60
! 7 Warning Signs
View Full Analysis

What is Zenith Drugs Other Operating Expense?

Zenith Drugs NSE:ZENITHDRUG -5.33% 36 Other Operating Expense is ₹426 Mil as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 36/100. The stock has 7 warning signs investors should review.

Zenith Drugs's Other Operating Expense for the six months ended in Mar. 2026 was ₹219 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹426 Mil.

Zenith Drugs's quarterly Other Operating Expense increased from Mar. 2025 (₹203 Mil) to Sep. 2025 (₹206 Mil) and increased from Sep. 2025 (₹206 Mil) to Mar. 2026 (₹219 Mil).

Zenith Drugs's annual Other Operating Expense increased from Mar. 2024 (₹159 Mil) to Mar. 2025 (₹287 Mil) and increased from Mar. 2025 (₹287 Mil) to Mar. 2026 (₹426 Mil).

Zenith Drugs Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Other Operating Expense Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Operating Expense
Get a 7-Day Free Trial 88.73 144.25 159.02 286.58 425.54

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only 55.53 149.40 202.87 206.44 219.09
NSE:ZENITHDRUG
36GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹426 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of ₹426 Mil mean?
Zenith Drugs (NSE:ZENITHDRUG) has a Other Operating Expense of ₹426 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' Other Operating Expense too high?
Zenith Drugs' current Other Operating Expense is ₹426 Mil. Overall, Zenith Drugs has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Other Operating Expense compare to ZTS?
Zenith Drugs' Other Operating Expense of ₹426 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current Other Operating Expense is ₹426 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Other Operating Expense of ₹426 Mil. The current Other Operating Expense is ₹426 Mil. Zenith Drugs' overall GF Score™ is 36/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Other Operating Expense is ₹426 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
36GF Score

Get the complete analysis for NSE:ZENITHDRUG

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹42.60
Price